It has been previously established from measurements of tau in CSF and postmortem studies of brain tissue that tau aggregation correlates with both neurodegeneration and the resultant cognitive decline temporally and spatially during progression of AD [23], [24]. This evidence concerns the gene MAPT and Alzheimer disease.